Nup88 expression is associated with myometrial invasion in endometrial carcinoma

International Journal of Gynecological Cancer

Volumn 20, Issue 5, 2010, Pages 804-808

  Schneider, José ^a,b   Martínez Arribas, Fernando ^b   Torrejón, Rafael ^c  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Endometrial carcinoma; Myometrial invasion; Nup88

Indexed keywords

MESSENGER RNA; NUCLEOPORIN; NUP88 PROTEIN; UNCLASSIFIED DRUG;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CLINICAL ARTICLE; DISEASE SEVERITY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; FROZEN SECTION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MYOMETRIUM; PAPILLARY CARCINOMA; PELVIS LYMPHADENECTOMY; PILOT STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALPINGOOOPHORECTOMY;

ADENOCARCINOMA; AGED; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MYOMETRIUM; NEOPLASM INVASIVENESS; NUCLEAR PORE COMPLEX PROTEINS; PILOT PROJECTS;

EID: 77956816455     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181dfaa6b     Document Type: Article

References (14)

1. Lanciano RM, Corn BW, Schultz DJ, et al. The justification for a surgical staging system in endometrial carcinoma. Radiother Oncol. 1993;28:189Y196.
2. Boronow RC, Morrow CP, Creasman WT, et al. Surgical staging in endometrial cancer: Clinical pathologic findings of a prospective study. Obstet Gynecol. 1984;63:825Y832.
3. Schneider J, Centeno MM, Sáez F, et al. Preoperative CA-125, CA 19.9 and nuclear magnetic resonance in endometrial carcinoma: Correlation with surgical stage. Tumor Biol. 1999;20:25Y29.
4. Fornerod M, Boer J, Van Baal S, et al. Interaction of cellular proteins with the leukemia specific fusion proteins DEKCAN and SET-CAN and their normal counterpart, the nucleoporin CAN. Oncogene. 1996;13:1801Y1808.
5. Bastos R, Ribas DP, Enarson M, et al. Nup84, a novel nucleoporin that is associated with CAN/nup214 on the cytoplasmic face of the nuclear pore complex. J Cell Biol. 1997;137:989Y1000.
6. Martínez N, Alonso A, Moragues D, et al. The nuclear pore complex protein Nup88 is overexpressed by tumor cells. Cancer Res. 1999;59:5408Y5411.
7. Gould VE, Martínez N, Orucevic A, et al. A novel, nuclear poreYassociated, widely distributed molecule overexpressed in oncogenesis and development. Am J Pathol. 2000;157:1605Y1613.
8. Schneider J, Linares R, Martinez-Arribas F, et al. Developing chick embryos express a protein which crossreacts with the nuclear pore complex protein Nup88 present in human tumors. Int J Dev Biol. 2004;48:339Y342.
9. Agudo D, Gomez-Esquer F, Martinez-Arribas F, et al. Nup88-mRNA overexpression is associated with high aggressiveness of breast cancer. Int J Cancer. 2004;109:717Y720.
10. Zhang ZY, Zhao ZR, Jiang L, et al. Nup88 expression in normal mucosa, adenoma, primary adenocarcinoma and lymph node metastasis in the colorectum. Tumor Biol. 2007;28:93Y99.
11. Zhang H, Schneider J, Rosdahl I. Expression of p16, p27, p53, p73 and Nup88 proteins in matched primary and metastatic melanoma cells. Int J Oncol. 2002;21:43Y48.
12. Brustmann H, Hager M. Nucleoporin 88 expression in normal and neoplastic squamous epithelia of the uterine cervix. Ann Diagn Pathol. 2009;13:303Y307.
13. Martinez-Arribas F, Martin-Garabato E, Zapardiel I, et al. Bax expression in untreated breast cancer: An immunocytometric study of 255 cases. Anticancer Res. 2008;28:2595Y2598.
14. Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial. J Natl Cancer Inst. 2008;100:1707Y1716.